Back to Agenda
[V7-S4] Introduction to Database Study I - Introduction
Session Chair(s)
Chieko Ishiguro, PhD, MPH
Section Chief of Clinical Epidemiology, Department of Data Science
National Center for Global Health and Medicine, Japan
Rei Maeda
Consultant
Independent Consultant for Drug PV, Japan
Database studies based on secondary data analysis of automated largescale health care databases, such as claims data and electronic medical records, have been widely acknowledged and employed in postmarketing evaluations overseas. This session will outline and discuss the current issues and challenges in fully introducing and quickly realizing database studies in Japan.
Speaker(s)
Introduction and Consideration
Hisashi Urushihara, DrPH
Keio University, Japan
Professor, Faculty of Pharmacy, Department of Pharmacy
The Role of Pharmacoepidemiological Study in Postmarketing Drug Safety Assessments
Maori Ito, MSc
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Office of Medical Informatics and Epidemiology
From Physician Based to Patient Based
Shinya Kimura
Japan Medical Data Center Co., Ltd., Japan
Chief Executive Officer / Chairman of the Board
Hospital Information System Database
Masaki Nakamura
Medical Data Vision Co.,Ltd., Japan
Senior Manager, EBM Division
Have an account?